Metraipolis › archive › dc_b6bddb0d3ee2

Targeting Glycolytic Plasticity to Overcome Therapy Resistance in Cancer Stem Cells: Mechanisms and Clinical Perspectives — Europe PMC PMID:42346134

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42346134
DOI
10.3390/cells15121107
License (as archived)
solo-consultazione
Archived
2026-10-19T08:11:04.676Z
SHA-256 of the archived text
e3c7af8a080653e30b1db8a2a618aefa70efc570f9039df4b4eb53c361800faa
Stable URL of this page
https://metraipolis.com/documento/dc_b6bddb0d3ee2

How to cite

Targeting Glycolytic Plasticity to Overcome Therapy Resistance in Cancer Stem Cells: Mechanisms and Clinical Perspectives — Europe PMC PMID:42346134 — Europe PMC (en), https://europepmc.org/article/MED/42346134 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b6bddb0d3ee2 (Metraipolis archive dc_b6bddb0d3ee2, sha256 e3c7af8a080653e30b1db8a2a618aefa70efc570f9039df4b4eb53c361800faa)
BibTeX
@misc{dcb6bddb0d3ee2,
  title = {Targeting Glycolytic Plasticity to Overcome Therapy Resistance in Cancer Stem Cells: Mechanisms and Clinical Perspectives — Europe PMC PMID:42346134},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42346134},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b6bddb0d3ee2; sha256 e3c7af8a080653e30b1db8a2a618aefa70efc570f9039df4b4eb53c361800faa},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42346134. Agents can read the archived copy with the MCP tool read_document.